Lv5
1390 积分 2023-12-12 加入
Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report
28天前
已完结
Timeline and outcomes of viral and fungal infections after Chimeric Antigen Receptor (CAR) T-cell therapy: A large database analysis
28天前
已完结
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma
28天前
已完结
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
28天前
已完结
Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities
28天前
已完结
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report
1个月前
已完结
Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)–T-Cell therapy
1个月前
已完结
Current understanding and management of CAR T cell-associated toxicities
1个月前
已完结
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies
1个月前
已完结
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel
1个月前
已完结
皖公网安备34019202002308
